Loading
Latest filing published 21 Feb 2023 for Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.).
No signal scores available.
Michael Grant McCune is a declared insider of Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.), with filings sourced from SEDI. We count 2 filings; the first trade dates from 17 March 2022 and the latest from 6 February 2023.
On the market, this insider has only sold: 1 sale, €6,597 in total. So far in 2023, the count stands at no purchases and 1 sale.
Most recently, on 21 February 2023, the filings show a transaction in Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations